Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Anterix 10-Q Report Highlights Strong Financial Position

Anterix Inc. has recently released its 10-Q report, which provides a detailed insight into the company's financial condition and operations. Anterix focuses on commercializing spectrum assets to enable targeted utility and critical infrastructure customers to deploy private broadband networks and solutions. The company offers CatalyX, an active ecosystem platform, complementary spectrum, Anterix Security Collective, and rural broadband services. Additionally, it holds licensed spectrum in the 900 MHz band throughout the contiguous United States, as well as Hawaii, Alaska, and Puerto Rico.

In the 10-Q report, under Item 1: Consolidated Financial Statements, Anterix Inc. reported total current assets of $50,062, including cash and cash equivalents of $29,534 as of December 31, 2025. The report also showed a total stockholders' equity of $235,951 as of the same period. In terms of financial performance, the company reported spectrum revenue of $1,573 for the three months ended December 31, 2025, and $4,543 for the nine months ended December 31, 2025. However, the company also reported a net loss of $6,601 for the same three-month period.

The report also discussed various financial activities, including net cash used in operating activities, investing activities, and financing activities. Notably, the company reported a net change in cash and cash equivalents and restricted cash of -$17,137 for the nine months ended December 31, 2025.

Furthermore, the report highlighted business developments, such as the partnership between Anterix and Crown Castle to introduce TowerX, a turnkey tower service that helps utilities accelerate buildout timelines.

Today the company's shares have moved 3.14% to a price of $25.29. For the full picture, make sure to review Anterix's 10-Q report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS